Pershing Square Holdings lost 7.3 percent in October, the firm,
which invests roughly $16 billion for state pension funds,
endowments and wealthy investors said on a Web site. The trouble
was largely related to a 47 percent tumble in the stock of
Valeant, a drug company Ackman added to his concentrated
portfolio earlier this year.
But another one of Ackman's big bets on Platform Specialty
Products also soured when it lost roughly 20 percent in the last
month.
Last year Pershing Square Holdings gained 40 percent.
(Reporting by Svea Herbst-Bayliss)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|